Table 1.
Established risk factors for pneumonia in children
| Prevalence | Mechanisms | |
|---|---|---|
| Not exclusively breastfeeding (children aged 0–5 months) | 61% of children aged 0–5 months globally3 | Suboptimal maternal antibody transmission; suboptimal nutrition |
| Underweight (weight-for-age <–2 SD) | 20·2% of children <5 years in low-income and middle-income countries.4 | Poorly characterised immune deficiency |
| Stunting (height-for-age <–2 SD) | 32·0% of children <5 years in low-income and middle-income countries4 | Poorly characterised immune deficiency |
| Severe wasting (weight-for-length <–3 SD) | 3·5% of children <5 years in low-income and middle-income countries4 | Poorly characterised immune deficiency |
| Zinc deficiency | 7·5–30% globally, all ages5 | Impairs various immune functions, including the integrity of respiratory cells during lung inflammation or injury |
| Exposure to household air pollution | Approximately 40% worldwide6 | Impairment of respiratory tract defence mechanisms, local oxidative stress, and inflammation |
| Non-vaccination | Haemophilus influenzae type b (30%); measles (2 doses) [36%]; Pneumococcus (3 doses of a conjugate vaccine) pertussis (as DTP3)[14%].7 | Disease-specific immunity |
SD= standard deviation. DTP3= Diphtheria-tetanus-pertussis vaccine.